Assembly Net Receivables from 2010 to 2026
| ASMB Stock | USD 26.22 0.83 3.27% |
Net Receivables | First Reported 2014-06-30 | Previous Quarter 400 K | Current Value 912 K | Quarterly Volatility 1.2 M |
Check Assembly Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Assembly Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 245 K, Interest Expense of 544.1 K or Selling General Administrative of 17.8 M, as well as many indicators such as Price To Sales Ratio of 3.63, Dividend Yield of 0.0 or PTB Ratio of 1.56. Assembly financial statements analysis is a perfect complement when working with Assembly Biosciences Valuation or Volatility modules.
Assembly | Net Receivables | Build AI portfolio with Assembly Stock |
Analyzing Assembly Biosciences's Net Receivables over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Receivables has evolved provides context for assessing Assembly Biosciences's current valuation and future prospects.
Latest Assembly Biosciences' Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Assembly Biosciences over the last few years. It is Assembly Biosciences' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Assembly Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Assembly Net Receivables Regression Statistics
| Arithmetic Mean | 1,626,529 | |
| Geometric Mean | 1,097,243 | |
| Coefficient Of Variation | 62.64 | |
| Mean Deviation | 909,495 | |
| Median | 2,274,000 | |
| Standard Deviation | 1,018,809 | |
| Sample Variance | 1T | |
| Range | 3.3M | |
| R-Value | (0.77) | |
| Mean Square Error | 450.9B | |
| R-Squared | 0.59 | |
| Significance | 0.0003 | |
| Slope | (155,331) | |
| Total Sum of Squares | 16.6T |
Assembly Net Receivables History
About Assembly Biosciences Financial Statements
Assembly Biosciences stakeholders use historical fundamental indicators, such as Assembly Biosciences' Net Receivables, to determine how well the company is positioned to perform in the future. Although Assembly Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Assembly Biosciences' assets and liabilities are reflected in the revenues and expenses on Assembly Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Assembly Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 360 K | 342 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock:Check out the analysis of Assembly Biosciences Correlation against competitors. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Assembly Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.60) | Revenue Per Share | Quarterly Revenue Growth 0.576 | Return On Assets | Return On Equity |
Assembly Biosciences's market price often diverges from its book value, the accounting figure shown on Assembly's balance sheet. Smart investors calculate Assembly Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Assembly Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Assembly Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Assembly Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.